Home 2023

Healthcare financing

Jura Bio Binds AI and SynBio to Develop Immune-Based Therapeutics
Artificial Intelligence

Jura Bio Binds AI and SynBio to Develop Immune-Based Therapeutics

Julianna LeMieux, PhD -
0
BPI News: Opening Keynote Offers Hopeful Outlook for Cell and Gene Therapy
Bioprocessing

BPI News: Opening Keynote Offers Hopeful Outlook for Cell and Gene Therapy

Julianna LeMieux, PhD -
0
How Science Competitions Inspire Innovation in Asia-Pacific
Insights

How Science Competitions Inspire Innovation in Asia-Pacific

Shannon Meirzon -
0
Alliance for Genomic Discovery Announces Five Founding Biopharma Members
Industry News

Alliance for Genomic Discovery Announces Five Founding Biopharma Members

Julianna LeMieux, PhD -
0
Switch Therapeutics Comes Out of Stealth to Advance First-of-its-Kind RNAi Technology
News

Switch Therapeutics Comes Out of Stealth to Advance First-of-its-Kind RNAi Technology

Kathy Vuksanaj -
4
Up or Down: Chroma Medicine Raises Stakes in Epigenetic Editing
GEN Edge

Up or Down: Chroma Medicine Raises Stakes in Epigenetic Editing

Alex Philippidis -
0
StockWatch: Analysts Mixed on Illumina after Q4 Results, Delivery of First NovaSeq X Plus System
Cancer

StockWatch: Analysts Mixed on Illumina after Q4 Results, Delivery of First NovaSeq X Plus System

Alex Philippidis -
0
IPO Raises $161M for GPCR-Based Drug Developer Structure Therapeutics
Drug Discovery

IPO Raises $161M for GPCR-Based Drug Developer Structure Therapeutics

Alex Philippidis -
0
Inside VC: Samir Kaul of Khosla Ventures on Evaluating and Managing Risk in 2023
Artificial Intelligence

Inside VC: Samir Kaul of Khosla Ventures on Evaluating and Managing Risk in 2023

Jonathan D Grinstein, PhD -
0
White House Continues Dedication to “End Cancer as We Know It”
Cancer

White House Continues Dedication to “End Cancer as We Know It”

Julianna LeMieux, PhD -
0
123...21Page 1 of 21
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.